BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9605006)

  • 1. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
    Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
    Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 protein expression in human leukemia and lymphoma cells.
    Koníková E; Kusenda J
    Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance].
    Ludwig WD; Reiter A; Schott G; Schwartz S; Thiel E
    Wien Klin Wochenschr; 1994; 106(8):231-2, 233-7. PubMed ID: 8023515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
    Li S; Juco J; Mann KP; Holden JT
    Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative immune phenotyping: a new dimension for the monitoring of haemopoietic malignancies.
    Lavabre-Bertrand T; George F; Brunet C; Sampol J
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):373-82. PubMed ID: 7892132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
    Koníková E; Kusenda J; Babusíková O; Glasová M
    Neoplasma; 1995; 42(5):227-34. PubMed ID: 8552200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J; Cáp J; Gyárfás J; Koubek K
    Neoplasma; 1998; 45(3):128-34. PubMed ID: 9717523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
    Knapp W; Strobl H; Majdic O
    Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype.
    Babusíková O; Tomová A
    Neoplasma; 2002; 49(5):312-8. PubMed ID: 12458329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow-cytometric quantitation in chronic leukemias.
    Lavabre-Bertrand T
    Eur J Histochem; 1996; 40 Suppl 1():33-8. PubMed ID: 8839697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular markers in acute myeloid leukemia diagnosis.
    Koníková E; Glasová M; Kusenda J; Babusíková O
    Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.